Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. (Q40632749)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

Herpes simplex virus type 1

1 reference

Oliver Wildner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Dennis Hoffmann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

791-802

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700638

19 December 2019

exact match

0 references

cites work

Gene therapy for cancer: what have we done and where are we going?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

p53-dependent cell death/apoptosis is required for a productive adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

The adenovirus type 5 E1A enhancer contains two functionally distinct domains: one is specific for E1A and the other modulates all early units in cis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenoviruses in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus Infection in Pediatric Liver Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Acute adenovirus hepatitis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Fatal disseminated adenovirus infection in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus infection after pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus infections in adult recipients of blood and marrow transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Gene therapy death prompts review of adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Gene therapy death--"everyone has to share in the guilt".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Inhibition of Adenovirus Replication in Vitro by Trifluridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Biochemistry and clinical applications of ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Adenovirus replication as an in vitro probe for drug sensitivity in human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Mechanism of action and selectivity of acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Methods for construction of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

Comparison of MTT and ATP-based assays for the measurement of viable cell number

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Recovery of new agent from patients with acute respiratory illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Respiratory virus infections during anticancer treatment in children.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Increasing incidence of adenovirus disease in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Disseminated adenovirus disease in immunocompromised and immunocompetent children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Evaluation of the efficacy of 2',3'-dideoxycytidine against adenovirus infection in a mouse pneumonia model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

A phase I study of intralesional administration of an adenovirus vector expressing the HSV-1 thymidine kinase gene (AdV.RSV-TK) in combination with escalating doses of ganciclovir in patients with cutaneous metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700638

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502232%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

19 December 2019

1016080129

0 references

1 reference